The human cathelicidin LL-37—A pore-forming antibacterial peptide and host-cell modulator D Xhindoli, S Pacor, M Benincasa, M Scocchi, R Gennaro, A Tossi Biochimica et Biophysica Acta (BBA)-Biomembranes 1858 (3), 546-566, 2016 | 365 | 2016 |
Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences N Ilić, M Novković, F Guida, D Xhindoli, M Benincasa, A Tossi, D Juretić Biochimica et Biophysica Acta (BBA)-Biomembranes 1828 (3), 1004-1012, 2013 | 96 | 2013 |
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 D Xhindoli, S Pacor, F Guida, N Antcheva, A Tossi Biochemical Journal 457 (2), 263-275, 2014 | 72 | 2014 |
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine D Xhindoli, F Morgera, U Zinth, R Rizzo, S Pacor, A Tossi Biochemical Journal 465 (3), 443-457, 2015 | 44 | 2015 |
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL‐37 S Pacor, F Guida, D Xhindoli, M Benincasa, R Gennaro, A Tossi Peptide Science 110 (5), e24087, 2018 | 7 | 2018 |
Caratterizzazione degli aspetti strutturali che determinano le attivitą biologiche della catelicidina antimicrobica dell'uomo LL-37 D Xhindoli Universitą degli studi di Trieste, 2014 | | 2014 |
Insights into structural features that affect the biological activities and mode of action of the human antimicrobial cathelicidin LL-37 D Xhindoli Universitą degli studi di Trieste, 2014 | | 2014 |